FI840323L - Foerfarande foer framstaellning av aminosubstituerade pyridazinderivat i position 3, vilka inverkar pao det centrala nervsystemet. - Google Patents

Foerfarande foer framstaellning av aminosubstituerade pyridazinderivat i position 3, vilka inverkar pao det centrala nervsystemet. Download PDF

Info

Publication number
FI840323L
FI840323L FI840323A FI840323A FI840323L FI 840323 L FI840323 L FI 840323L FI 840323 A FI840323 A FI 840323A FI 840323 A FI840323 A FI 840323A FI 840323 L FI840323 L FI 840323L
Authority
FI
Finland
Prior art keywords
pyridazinderivat
nervsystemet
inverkar
aminosubstituerade
vilka
Prior art date
Application number
FI840323A
Other languages
English (en)
Other versions
FI78691C (fi
FI78691B (fi
FI840323A0 (fi
Inventor
Jean-Pierre Chambon
Kathleen Biziere
Camille-Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of FI840323A0 publication Critical patent/FI840323A0/fi
Publication of FI840323L publication Critical patent/FI840323L/fi
Application granted granted Critical
Publication of FI78691B publication Critical patent/FI78691B/fi
Publication of FI78691C publication Critical patent/FI78691C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI840323A 1983-01-27 1984-01-26 Foerfarande foer framstaellning av i position 3-substituerade pyridazinderivat, vilka inverkar pao det centrala nervsystemet. FI78691C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8301234 1983-01-27
FR8301234A FR2540113A1 (fr) 1983-01-27 1983-01-27 Acides derives de la pyridazine actifs sur le systeme nerveux central

Publications (4)

Publication Number Publication Date
FI840323A0 FI840323A0 (fi) 1984-01-26
FI840323L true FI840323L (fi) 1984-07-28
FI78691B FI78691B (fi) 1989-05-31
FI78691C FI78691C (fi) 1989-09-11

Family

ID=9285330

Family Applications (1)

Application Number Title Priority Date Filing Date
FI840323A FI78691C (fi) 1983-01-27 1984-01-26 Foerfarande foer framstaellning av i position 3-substituerade pyridazinderivat, vilka inverkar pao det centrala nervsystemet.

Country Status (27)

Country Link
US (1) US4721711A (fi)
EP (1) EP0117779B1 (fi)
JP (1) JPS59141564A (fi)
KR (1) KR910000638B1 (fi)
AR (1) AR240045A1 (fi)
AT (1) ATE48417T1 (fi)
AU (2) AU2372984A (fi)
CA (1) CA1238637A (fi)
DD (1) DD220026A5 (fi)
DE (1) DE3480653D1 (fi)
DK (1) DK162985C (fi)
ES (1) ES8500243A1 (fi)
FI (1) FI78691C (fi)
FR (1) FR2540113A1 (fi)
HU (1) HU193890B (fi)
IE (1) IE57054B1 (fi)
IL (1) IL70756A (fi)
MA (1) MA20018A1 (fi)
NO (1) NO840313L (fi)
NZ (1) NZ206945A (fi)
OA (1) OA07644A (fi)
PH (1) PH21162A (fi)
PL (1) PL142340B1 (fi)
PT (1) PT77993B (fi)
SG (1) SG93690G (fi)
YU (1) YU14284A (fi)
ZA (1) ZA84502B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
DE3664772D1 (en) * 1985-01-14 1989-09-07 Boehringer Ingelheim Kg 12-amino pyridazinoû4',5':3,4¨pyrroloû2,1-a¨isoquinolines, process for their preparation and use
US5082939A (en) * 1987-01-08 1992-01-21 I.S.F. Societa Per Azioni Pyridazine derivatives
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
EP2264014A1 (en) * 2001-08-31 2010-12-22 Université Louis Pasteur Substituted pyridazines as anti-inflammatory agents and protein kinase inhibitors
WO2006050389A2 (en) 2004-11-02 2006-05-11 Northwestern University Pyridazine compounds, compositions and methods
EP1812007B1 (en) * 2004-11-02 2011-09-07 Northwestern University Pyridazine compounds and methods
WO2007127448A2 (en) * 2006-04-28 2007-11-08 Northwestern University Salts of pyridazine compounds
US20090325973A1 (en) * 2006-04-28 2009-12-31 Watterson D Martin Formulations containing pyridazine compounds
WO2007127474A2 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
EP2142498A2 (en) * 2007-04-02 2010-01-13 Institute for Oneworld Health Cftr inhibitor compounds and uses thereof
US8207205B2 (en) * 2008-04-21 2012-06-26 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
WO2009131958A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising triazine derivatives
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
US20090270398A1 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
WO2010033626A1 (en) * 2008-09-19 2010-03-25 Institute For Oneworld Health Compounds, compositions and methods comprising imidazole and triazole derivatives
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
US20100267706A1 (en) * 2009-04-20 2010-10-21 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions

Also Published As

Publication number Publication date
CA1238637A (en) 1988-06-28
IE57054B1 (en) 1992-04-08
ES529081A0 (es) 1984-10-01
AU2372984A (en) 1984-08-02
MA20018A1 (fr) 1984-10-01
SG93690G (en) 1991-01-18
EP0117779A1 (fr) 1984-09-05
IE840149L (en) 1984-07-27
DE3480653D1 (de) 1990-01-11
PT77993B (fr) 1986-04-10
EP0117779B1 (fr) 1989-12-06
AU652118B2 (en) 1994-08-18
FR2540113A1 (fr) 1984-08-03
DK38984D0 (da) 1984-01-27
NZ206945A (en) 1987-07-31
NO840313L (no) 1984-07-30
ES8500243A1 (es) 1984-10-01
PH21162A (en) 1987-08-05
FI78691C (fi) 1989-09-11
DD220026A5 (de) 1985-03-20
AR240045A1 (es) 1990-01-31
AU2142188A (en) 1989-03-16
KR910000638B1 (ko) 1991-01-31
US4721711A (en) 1988-01-26
DK38984A (da) 1984-07-28
PL245931A1 (en) 1985-07-16
DK162985C (da) 1992-06-01
FI78691B (fi) 1989-05-31
DK162985B (da) 1992-01-06
IL70756A0 (en) 1984-04-30
FI840323A0 (fi) 1984-01-26
OA07644A (fr) 1985-05-23
PL142340B1 (en) 1987-10-31
ATE48417T1 (de) 1989-12-15
FR2540113B1 (fi) 1985-05-17
IL70756A (en) 1987-03-31
YU14284A (en) 1986-12-31
HU193890B (en) 1987-12-28
KR840007586A (ko) 1984-12-08
ZA84502B (en) 1984-09-26
JPS59141564A (ja) 1984-08-14
PT77993A (fr) 1984-02-01

Similar Documents

Publication Publication Date Title
ATE40361T1 (de) 2,2'-iminobisaethanol-derivate.
FI840323L (fi) Foerfarande foer framstaellning av aminosubstituerade pyridazinderivat i position 3, vilka inverkar pao det centrala nervsystemet.
FI842597A0 (fi) 1,2,4-triazol-3-on- depressionslaekemdel.
FI864237L (fi) Foerfarande foer framstaellning av 1,6-diklor-1,6-dideoxi- -d-fruktofuranosyl-4-klor-4-deoxi- -galaktopyranosider.
FI841448L (fi) Anordning foer upprullning av en materialbana, speciellt en pappersbana, pao en hylsa.
FI843169A0 (fi) Substituerade 2,6-substituerade pyridinfoereningar.
FI843779L (fi) Depressionslaekemedel, 1,2,4-triazolonfoereningar.
FI80881B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,5-bentsotiazepinderivat.
FI853255A0 (fi) Foerfarande foer framstaellning av 6-klor-n-metyl-2,3,4,5-tetrahydro-1h-3-bensazepin.
FI861416L (fi) Foerfarande foer framstaellning av farmakologiskt aktiva 2,3,4,5-tetrahydro-lh-3-benzazepiner.
FI860033A0 (fi) Anordning foer faestande av platta isolermaterial, i synnerhet vaermeisoleringsmattor eller -papp, pao tunnvaeggiga underlag, saosom plaoten i ventilationskanaler.
FI844051L (fi) Foerfarande foer dehalogenering av 6, 6-dibrompenicillansyra-1,1-dioxid.
FI853686A0 (fi) Foerfarande foer framstaellning av 2,4 -diklor-5-fluorbensoesyra.
FI852899A0 (fi) Foerfarande foer framstaellning av fenylsubstituerade 2,4,6,8-nonatetraensyror.
FI86060B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-naftalendioner.
FI862343A7 (fi) Foerfarande foer framstaellning av terapeutiskt verkande 1,4-dihydropyridinfoereningar.
FI860247L (fi) Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner.
FI841336A7 (fi) Foerfarande foer framstaellning av symmetriska 1,4-dihydropyridin-dikarboxyl-syraestrar.
FI842085L (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/hept-2- en-derivat.
FI855182L (fi) Foerfarande foer framstaellning av 1,3 -disubstituerade tetrahydropyridiner.
FI861275A7 (fi) Foerfarande foer framstaellning av farmakologiskt aktiva 16,17-asetalsubstituerade androstan-17 -karboxylsyraestrar.
FI865244A7 (fi) Foerfarande foer framstaellning av optiskt aktiva 2-klor-12-(3-dimetylamino-2-metylpropyl)-12h-dibenzo-/d,g//1,3,6/ dioxazociner.
FI853585A0 (fi) Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner.
FI77034B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 4-oxo-4h-pyrimido/2,1-a/isokinolin-3- karboxylsyraderivat.
FI855017L (fi) Foerfarande foer framstaellning av 26,26,26-trifluor-1 ,25-dihydroxikolekalciferol.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: SANOFI